Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
about
The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseThe homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviourNeuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia.Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.Neuropeptides and the microbiota-gut-brain axisTherapeutic potential of neuropeptide Y (NPY) receptor ligands.A fundamental bimodal role for neuropeptide Y1 receptor in the immune systemNeuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.Emerging neuropeptide targets in inflammation: NPY and VIPInteraction between diet and gastrointestinal endocrine cells.Enteric nervous system in the small intestine: pathophysiology and clinical implications.Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.Potential roles of enteric glia in bridging neuroimmune communication in the gut.Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferation.Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat.The Gut's Little Brain in Control of Intestinal Immunity.Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat.Granisetron ameliorates acetic acid-induced colitis in rats.Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.Interplay between sympathetic nervous system and inflammation in aseptic loosening of hip joint replacement
P2860
Q26774660-EA4EA135-32A3-444E-8C81-D0D6754986C4Q27002574-1BF9B50F-113E-49A3-A628-611B71D9B70CQ34439028-AC0993FF-6289-46B5-A3FE-58C7CFF74604Q35130566-F786DBF9-2F5B-4002-928D-791C5F5612A5Q35178233-CE7B7AE0-AE84-43C8-826F-EFE8C93A1CD3Q36088880-B7A0A650-9AA1-4E47-9453-84E3CFFEEB9BQ36403973-6FE1CA4F-6CDE-4C80-8223-BABD1E0CD096Q36451817-561253DD-7603-4BC3-AF6D-82306672051AQ36923640-AA50DEB2-0D8F-49C3-B7A6-EA280607D9A6Q36953864-AEA239C9-C445-432E-A0C3-72AB16D464DFQ37118938-C5E5415E-2810-4D3D-9C9C-14D8344C24E1Q38622923-1F0BEAFE-E6B3-4DBB-8167-9F35CE3F10DFQ39031805-B39F9B5E-A803-48B8-9BBB-F9B567637DF0Q39049151-A232960C-D658-4ED0-89E7-D66C0F63D520Q39179725-FF0F473B-60CA-44DA-84A7-7758343B7084Q39650004-98ED314E-C469-4A66-ACB6-3CA6ADFA8A3BQ40566816-CD04854C-5F75-42C6-9968-92CE038F1D3DQ41873397-4ADF5638-00A2-4403-B2DA-2C8850D58D6AQ43162706-B03E5F74-64BD-45F8-8D77-D9A28BCEBB7BQ43669793-FEE9727F-C819-4308-8B77-8917351FB759Q49055159-496B63BB-9982-46B6-A58D-F561ACE1DBC5Q58099155-7F3671D0-BBC5-4CB0-BE17-4200DC79BCF5
P2860
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@en
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@nl
type
label
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@en
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@nl
prefLabel
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@en
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@nl
P2093
P2860
P356
P1476
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.
@en
P2093
Björn Rozell
Guilherme Lucas
Hessameh Hassani
P2860
P304
P356
10.1152/AJPGI.00182.2004
P577
2004-10-21T00:00:00Z